🇺🇸 FDA
Pipeline program

Dengzhan Shengmai capsule

2006BAI04A02

Approved small_molecule completed

Quick answer

Dengzhan Shengmai capsule for Stroke is a Approved program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Stroke
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials